Protease inhibitor use during pregnancy: is there an obstetrical risk?
Tuomala
Ruth E
RE
Yawetz
Sigal
S
D005260:Female; D015658:HIV Infections / Q000517:prevention & control* / Q000635:transmission; D017320:HIV Protease Inhibitors / Q000009:adverse effects*; D006801:Humans; D018445:Infectious Disease Transmission, Vertical / Q000517:prevention & control*; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000188:drug therapy*; D011256:Pregnancy Outcome; D047928:Premature Birth / Q000453:epidemiology; D012306:Risk
D017320:HIV Protease Inhibitors